ArticlePDF Available

Abstract

Despite a decreasing gender gap in exercise participation, there still remains a significant under-representation of women included in sport and exercise medicine research studies.1 A review of 1382 sport and exercise research studies involving over 6 million participants, from 2011 to 2013, found the representation of women to be 39%.1 The complexities of the menstrual cycle are considered major barriers to the inclusion of women in clinical trials. Historically, partially due to concerns of potentially damaging unborn fetuses, medical trials—including drug trials—were conducted solely in men. Further, women were perceived …
Sport, exercise and the menstrual
cycle: where is the research?
G Bruinvels,
1,2,3
R J Burden,
2,3,4
A J McGregor,
5
K E Ackerman,
6
M Dooley,
7
T Richards,
1
C Pedlar
2,6
Despite a decreasing gender gap in exer-
cise participation, there still remains a sig-
nicant under-representation of women
included in sport and exercise medicine
research studies.
1
A review of 1382 sport
and exercise research studies involving
over 6 million participants, from 2011 to
2013, found the representation of women
to be 39%.
1
The complexities of the men-
strual cycle are considered major barriers
to the inclusion of women in clinical
trials.
Historically, partially due to concerns
of potentially damaging unborn fetuses,
medical trialsincluding drug trials
were conducted solely in men. Further,
women were perceived as more physiolo-
gically variable, therefore utilising only
male participants would allow meaningful
results with fewer participants and less
funding. Since men were viewed as ade-
quate proxies for women, the years of
exclusion of female participants from
research were considered inconsequential.
However, it is now known that women
can respond very differently to drug
treatments than men. Evidence suggests
that women are almost twice more likely
to have an adverse reaction to a drug
than their male counterparts, and 80% of
drugs withdrawn from the market are
due to unacceptable side effects in
women.
2
When research involving exercise meta-
bolism includes women, participants are
often tested in the early follicular phase of
their menstrual cycle, when hormone
levels are at their lowest, in order to mini-
mise the possible impacts oestradiol and
progesterone may have on the study out-
comes.
3
This type of research practice
leaves much ambiguity around how such
hormones may inuence the unique phy-
siological processes in women, from
blood pressure to substrate metabolism,
thus perpetuating the signicant gap in
understanding how the menstrual cycle
impacts exercise performance. Sheel
4
recently described a number of sex differ-
ences in the physiological response to
exercise, likely caused in part by ovarian
hormones, highlighting a lack of under-
standing and a need for further research.
We recently reported that 41.7% of
exercising women believe their menstrual
cycle has a negative impact on exercise
training and performance.
5
However,
largely due to the dearth of sports and
exercise research in women, explanations
for this are lacking. Heavy menstrual
bleeding with unknown or undiagnosed
iron deciency could be a cause but this is
speculative.
There is a clear need to gain better
understanding of female physiology and
to dene the effects of the cyclical varia-
tions in hormones, both positive and
negative, on athletic performance. Also, a
greater understanding of the menstrual
cycle is needed to address the reported
negative impacts on exercise training
in order to encourage participation and
avoid further disparity in gender
representation.
Twitter Follow Georgie Bruinvels at @gbruinvels and
Richard Burden @rich_burden, Charles Pedlar
@pedlarcr
Contributors GB, RJB, AJM, KEA, MD, TR and CP all
participated in manuscript preparation.
Competing interests None declared.
Provenance and peer review Not commissioned;
externally peer reviewed.
To cite Bruinvels G, Burden RJ, McGregor AJ, et al.
Br J Sports Med Published Online First: [please include
Day Month Year] doi:10.1136/bjsports-2016-096279
Accepted 26 April 2016
Br J Sports Med 2016;0:1.
doi:10.1136/bjsports-2016-096279
REFERENCES
1 Costello JT, Bieuzen F, Bleakley CM. Where are all the
female participants in Sports and Exercise Medicine
research? Eur J Sport Sci 2014;14:84751.
2 Rademaker M. Do women have more adverse drug
reactions? Am J Clin Dermatol 2001;2:34951.
3 Oosthuyse T, Bosch AN. The effect of the menstrual
cycle on exercise metabolism: implications for exercise
performance in eumenorrhoeic women. Sports Med
2010;40:20727.
4 Sheel AW. Sex differences in the physiology of
exercise: an integrative perspective. Exp Physiol
2016;101:2112.
5 Bruinvels G, Burden R, Brown N, et al. The prevalence
and impact of heavy menstrual bleeding (menorrhagia)
in elite and non-elite athletes. PLoS ONE 2016;11:
e0149881.
1
University College London, London, UK;
2
St Marys
University, Twickenham, UK;
3
ORRECO Ltd, Institute of
Technology, Sligo, Ireland;
4
English Institute of Sport,
Loughborough, UK;
5
Brown University, Providence,
Rhode Island, USA;
6
Massachusetts General Hospital,
Boston, Massachusetts, USA;
7
The Poundbury Clinic,
Dorchester, Dorset, UK
Correspondence to G Bruinvels, Division of Surgery
and Interventional Science, University College London,
21 University Street, London WC1E 6AU, UK; georgie.
bruinvels@ucl.ac.uk, @gbruinvels
Bruinvels G, et al.Br J Sports Med Month 2016 Vol 0 No 0 1
Editorial
BJSM Online First, published on June 6, 2016 as 10.1136/bjsports-2016-096279
Copyright Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd under licence.
group.bmj.com on June 8, 2016 - Published by http://bjsm.bmj.com/Downloaded from
where is the research?
Sport, exercise and the menstrual cycle:
Richards and C Pedlar
G Bruinvels, R J Burden, A J McGregor, K E Ackerman, M Dooley, T
published online June 6, 2016Br J Sports Med
http://bjsm.bmj.com/content/early/2016/05/17/bjsports-2016-096279
Updated information and services can be found at:
These include:
References
#BIBL
http://bjsm.bmj.com/content/early/2016/05/17/bjsports-2016-096279
This article cites 5 articles, 0 of which you can access for free at:
service
Email alerting box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections
(38)Press releases
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on June 8, 2016 - Published by http://bjsm.bmj.com/Downloaded from
... The rise of women in sports does not seem to match their presence in sport and exercise research [1]. When considered, they are asked to take part during the early follicular phase (EFP) of their menstrual cycle (MC), when estrogen and progesterone hormone levels remain low, minimizing their potential impact on study outcomes [1]. ...
... The rise of women in sports does not seem to match their presence in sport and exercise research [1]. When considered, they are asked to take part during the early follicular phase (EFP) of their menstrual cycle (MC), when estrogen and progesterone hormone levels remain low, minimizing their potential impact on study outcomes [1]. Therefore, there is a need to explore women's performance response to the rest of the MC phases, which is remarkable from their perceptive standpoint [2]. ...
Article
Full-text available
This study aimed to explore the effect of the menstrual cycle (MC) phases (i.e., early follicular phase [EFP], late follicular phase [LFP], and mid-luteal phase [MLP]) on the repetitions performed to momentary failure in back squat and bench press exercises, as well as to determine subsequent fatigue (i.e., change in countermovement jump [CMJ], perceived effort, and muscle soreness). Twelve physically active eumenorrheic women performed a back squat and bench press set to momentary failure at 80% of the one-repetition maximum during the EFP, LFP, and MLP. The results revealed that subjects were able to perform 2.2 [0.2 to 4.2] more repetitions in the LFP with respect to the EFP for the back squat exercise (p = 0.009), but no significant differences were observed for the bench press (p = 0.354). The EFP displayed a larger CMJ height drop (−0.86 [−1.71 to −0.01] cm) with respect to the LFP (0.01 [−0.57 to 0.58] cm) and the MLP (−0.36 [−1.15 to 0.43] cm). Neither the perceived effort of each set to failure nor the resulting muscle soreness differed between MC phases. Therefore, practitioners should be aware that the MC could condition the repetitions available to momentary failure and the resulting allostatic load.
... Menstruating women who have natural menstrual cycles (MC) or those who use intermittent hormonal contraception (HC) experience variations in female sex steroid hormones, notably estradiol and progesterone [1], guided by the gonadotropic axis or induced by the concentration levels of their contraceptive method. These hormonal fluctuations may influence women's wellness on multiple levels, affecting parameters such as sleep quality [2], mood [3], or fitness [4,5], and may be accompanied by symptoms [6]. Additionally, hormones may impact fatigue, cardiovascular, muscular, and metabolic functions, as well as mood and sleep disturbances, which can modulate both training adaptations and athletic performance [7][8][9]. ...
Article
Full-text available
The purpose of the study is to identify variations in wellness parameters among elite female athletes, considering simultaneously the influence of natural menstrual cycle (MC) or hormonal contraception (HC) phases and weekly and seasonal variations. A total of 54 elite female athletes were followed up with through a 6-month daily monitoring of their reported fitness, sleep quality, mood, and menstrual symptoms. Estimated cycle phases, days of the week, and seasons were all integrated into a single model to study cyclicities concomitantly. A total of 263 cycles were analyzed, totaling 7370 pieces of daily self-reported data. We observed more frequent symptoms during the menstruation and the pause phase. Reported fitness was greater in the mid-cycle and mood was lower at the end of the cycle for the MC group. Wellness parameters were rather stable for HC users. For both groups, symptoms were more frequent in summer. Reported fitness levels were lower on Monday, while mood scores were highest on Saturday and Sunday. In summer and autumn, fitness, sleep quality, and mood were greater. A cyclical wellness rhythm was identified in the menstrual cycle and persists even when considering weekdays and seasons cyclicities. This comprehensive approach helps to identify physiological influence on human behaviors, considering the specificities of women.
Article
Background In 2014, Costello and colleagues published a sentinel paper spotlighting the large disparity of female versus male representation within sports science and sports medicine (SSSM) research. Purpose To (1) revisit the method published by Costello et al a decade later to evaluate female representation and (2) ascertain whether study designs account for menstrual status. Study Design Systematic Review; Level of evidence, 4. Methods All original and epidemiologic research of live human participants from the journals Medicine and Science in Sports and Exercise, British Journal of Sports Medicine, and the American Journal of Sports Medicine were included from January 2021 to August 2023. Number of male and female participants for each study was analyzed. A menstrual-status tiering system published by Smith et al was used to classify the consideration of female participants’ menstrual status in study design. Results A total of 1441 studies and 40,152,860 participants were included in this analysis. This included 17,648,509 (43.95%) female participants. The mean proportion of female participants per study was 40.22%, and 103 (7.15%) studies included only female participants compared with 268 (18.6%) male-only studies. A total of 66 (5.6%) studies included menstrual-status considerations in their study design with 7.7 (0.7%) and 5.5 (0.5%) receiving a silver or gold classification, respectively, for design considerations. Conclusion Our investigation into the representation of female athletes in SSSM research found an increase in female participation from 39% to 43.95% of total participants over the past decade. While the overall number of female participants rose in the years 2021 to 2023, there remains a significant disparity in female representation in SSSM research compared with male participants. Additionally, we found that the inclusion of menstrual status in study designs has been limited, with few studies considering this crucial variable.
Poster
Full-text available
O Crossfit é uma modalidade esportiva que tem ganhado popularidade nos últimos anos no Brasil e no Mundo. Em 2015, estimou-se a presença de 40000 praticantes em território nacional, sendo cerca de 42,9% do sexo feminino. A saúde da mulher atleta envolve particularidades como a flutuação hormonal e sintomas do ciclo menstrual, cujo impacto na performance esportiva ainda não é completamente compreendido. O objetivo deste trabalho é avaliar a percepção de como o ciclo menstrual e os sintomas associados a ele impactam na performance esportiva das mulheres praticantes de Crossfit e na frequência nos treinos. Saúde da mulher no Crossfit: ciclo menstrual, contracepção e performance INTRODUÇÃO E OBJETIVO Foi realizado um estudo observacional por meio da aplicação de questionário eletrônico em atletas de CrossFit do sexo feminino, praticantes há pelo menos 6 meses, totalizando 120 atletas de 15 a 59 anos. Todas as participantes concordaram com o Termo de Consentimento Livre Esclarecido e o estudo foi aprovado pelo Comitê de Ética da instituição. O questionário incluiu idade, dados antropométricos, caracterização do ciclo menstrual e sintomas associados, percepção de queda na performance, frequência nos treinos e uso de métodos contraceptivos. CASUÍSTICA E MÉTODO Variações hormonais intrínsecas à fisiologia feminina estão relacionadas com o rendimento esportivo na literatura atual. Durante o período menstrual, a queda do estrogênio e a presença de cólicas e outros sintomas seriam responsáveis pela redução na performance. Já o uso de método contraceptivo hormonal esteve relacionado a uma menor percepção da queda de desempenho neste estudo (66% contra 83,5%). Tal achado diverge dos estudos atuais, que relacionam níveis de estrogênio e progestágenos suprimidos pelo método hormonal com um menor rendimento esportivo. Entretanto, a comparação realizada neste estudo foi entre o período menstrual e demais fases do ciclo, sendo a menor variação hormonal nessas atletas uma explicação possível para esse resultado. Além disso, o controle dos sintomas menstruais também parece estar relacionado a uma melhor percepção de rendimento nos treinos e a um menor número de faltas. DISCUSSÃO Aproximadamente um terço das mulheres praticantes de CrossFit avaliadas já deixou de treinar por estar menstruada e 75,8% referem piora da performance no mesmo período. Porém, no grupo que utiliza métodos contraceptivos hormonais, essas porcentagens foram menores. Esses achados reforçam a necessidade de individualização na periodização do treino visando ganho de performance em mulheres praticantes de CrossFit. A presença de sintomas menstruais e a percepção da mulher sobre as alterações que sofre durante o ciclo menstrual devem ser levadas em consideração para um melhor resultado e escolha do método contraceptivo.
Article
Purpose: To examine the relationship between menstrual cycle (MC) phase-dependent fluctuations of estrogen and progesterone and virtual cycling race performance, with a secondary aim of correlating perceived MC-related symptoms with performance. Methods: In a novel observational study design, thirty-seven female cyclists/triathletes not using any hormonal contraception completed one virtual cycling race [19.5 km time trial (TT)] per week across a one-month period (totaling four races). Participants completed MC characterization and tracking, including urinary ovulation kits, across two complete MCs. Venous blood samples were collected within 21 h of racing to determine serum 17-β-estradiol and progesterone concentrations, as well as an assessment of self-reported, perceived race-day MC and gastrointestinal (GI) symptoms, which were all then correlated to race performance. Results: There was no relationship between race completion time and individual estradiol (r = -0.001, p = 0.992 ) or progesterone (r = -0.023, p = 0.833 ) concentrations. There was no difference between race time between MC phases (follicular/luteal, p = 0.238 ), whether MC bleeding or not bleeding ( p = 0.619 ) and ovulating or not ovulating ( p = 0.423 ). The total number of perceived MC symptoms recorded on race day was positively correlated to increased race time [r = 0.268 (95% CI 0.056 to 0.457), p = 0.014 ], as was the number of GI symptoms of at least “moderate” severity before the race (r = 0.233 [95% CI 0.021 to 0.425], p = 0.031 ), but not post-race (r = 0.022, p = 0.841 ). Conclusions: When implementing a novel, virtual cycling race, fluctuations in ovarian hormone concentrations across the MC do not appear to affect real-world cycling performance among trained cyclists, while perceived negative MC and GI symptoms may relate to impaired performance. Therefore, the management of negative MC and GI symptoms appears important for athletic performance enhancement or to mitigate performance decline.
Article
Este artículo provee una propuesta de inclusión de la salud menstrual en la agenda de la bioética que parte del diagnóstico de que se trata de un problema subrepresentado en la disciplina. Se analizan casos ejemplificadores y actuales de este problema, se argumenta la necesidad de un abordaje bioético urgente acerca de salud menstrual que entrelace las perspectivas transfeministas, interseccionales y de derechos humanos. Lo anterior, en vistas de contribuir a que se garanticen los derechos de quienes menstrúan, especialmente en relación con la investigación médica, y con el acceso y la atención en salud.
Chapter
Full-text available
Stigma and taboo hinder research and education on menstruation all over the world. While the body of literature has grown in recent years, studies on the role of menstruation and menstrual health in the context of sport and physical activity lags behind other areas (Zipp & Mwambwa, 2023; Goorevich, 2023; Brown et al., 2021; Bruinvels et al., 2017). In this chapter, we explore the experiences of menstruation and menstrual health among adolescent girls in Zambia. This study, drawing on cross-disciplinary research in international development, sport, health, and other social sciences, fills an important gap in the research on menstruation. The voices of young people from the Global South are often absent in menstruation research (Zipp et al., 2022; Barrington et al., 2021; Bobel et al., 2020; Bobel, 2018; Hennegan & Montgomery, 2016; Sommer & Sahin, 2013) and this study is centred on their experiences and perspectives. This research also examines the impact of menstrual cycles on sport experiences, participant understandings of menstrual health, and the potential role of sport and physical activity in menstrual health education. Studying sport and menstrual health offers an embodied approach that is centred on the physical experiences of the menstrual cycle, while also exploring the deeply gendered social context of sport and physical activity (Zipp & Mwambwa, 2023; Brown et al., 2021; Heather et al., 2021; Zipp et al., 2019).
Article
Full-text available
The female hormones, oestrogen and progesterone, fluctuate predictably across the menstrual cycle in naturally cycling eumenorrhoeic women. Other than reproductive function, these hormones influence many other physiological systems, and their action during exercise may have implications for exercise performance. Although a number of studies have found exercise performance and in particular, endurance performance to vary between menstrual phases, there is an equal number of such studies reporting no differences. However, a comparison of the increase in the oestrogen concentration (E) relative to progesterone concentration (P) as the E/P ratio (pmol/nmol) in the luteal phase in these studies reveals that endurance performance may only be improved in the mid-luteal phase compared with the early follicular phase when the E/P ratio is high in the mid-luteal phase. Furthermore, the late follicular phase, characterized by the pre-ovulatory surge in oestrogen and suppressed progesterone concentrations, tends to promote improved performance in a cycling time trial and future studies should include this menstrual phase. Menstrual phase variations in endurance performance may largely be a consequence of changes to exercise metabolism stimulated by the fluctuations in ovarian hormone concentrations. The literature suggests that oestrogen may promote endurance performance by altering carbohydrate, fat and protein metabolism, with progesterone often appearing to act antagonistically. Details of the ovarian hormone influences on the metabolism of these macronutrients are no longer only limited to evidence from animal research and indirect calorimetry but have been verified by substrate kinetics determined with stable tracer methodology in eumenorrhoeic women. This review thoroughly examines the metabolic perturbations induced by the ovarian hormones and, by detailed comparison, proposes reasons for many of the inconsistent reports in menstrual phase comparative research. Often the magnitude of increase in the ovarian hormones between menstrual phases and the E/P ratio appear to be important factors determining an effect on metabolism. However, energy demand and nutritional status may be confounding variables, particularly in carbohydrate metabolism. The review specifically considers how changes in metabolic responses due to the ovarian hormones may influence exercise performance. For example, oestrogen promotes glucose availability and uptake into type I muscle fibres providing the fuel of choice during short duration exercise; an action that can be inhibited by progesterone. A high oestrogen concentration in the luteal phase augments muscle glycogen storage capacity compared with the low oestrogen environment of the early follicular phase. However, following a carbo-loading diet will super-compensate muscle glycogen stores in the early follicular phase to values attained in the luteal phase. Oestrogen concentrations of the luteal phase reduce reliance on muscle glycogen during exercise and although not as yet supported by human tracer studies, oestrogen increases free fatty acid availability and oxidative capacity in exercise, favouring endurance performance. Evidence of oestrogen's stimulation of 5'-AMP-activated protein kinase may explain many of the metabolic actions of oestrogen. However, both oestrogen and progesterone suppress gluconeogenic output during exercise and this may compromise performance in the latter stages of ultra-long events if energy replacement supplements are inadequate. Moreover, supplementing energy intake during exercise ith protein may be more relevant when progesterone concentration is elevated compared with menstrual phases favouring a higher relative oestrogen concentration, as progesterone promotes protein catabolism while oestrogen suppresses protein catabolism. Furthermore, prospective research ideas for furthering the understanding of the impact of the menstrual cycle on metabolism and exercise performance are highlighted.
Article
Full-text available
To identify the prevalence and impact of heavy menstrual bleeding (HMB) in exercising females where anemia may have a significant effect on training and performance a 'Female Health Questionnaire' was designed incorporating a validated diagnostic HMB series, demographics, exercise ability data, training status, anemia, iron supplementation and whether the menstrual cycle had affected training and performance. The survey was conducted in two stages; initially online, advertised via social media, and then repeated via face-to-face interviews with runners registered for the 2015 London Marathon. 789 participants responded to the online survey, and 1073 completed the survey at the marathon. HMB was reported by half of those online (54%), and by more than a third of the marathon runners (36%). Surprisingly, HMB was also prevalent amongst elite athletes (37%). Overall, 32% of exercising females reported a history of anemia, and 50% had previously supplemented with iron. Only a minority (22%) had sought medical advice. HMB is highly prevalent in exercising females, associated with self-reported anemia, increased use of iron supplementation and a perceived negative impact on performance. Further research is needed to investigate the impact of HMB, iron deficiency and anemia in exercising females.
Article
Full-text available
Abstract The aim of this study is to estimate the ratio of male and female participants in Sports and Exercise Medicine research. Original research articles published in three major Sports and Exercise Medicine journals (Medicine and Science in Sports and Exercise, British Journal of Sports Medicine and American Journal of Sports Medicine) over a three-year period were examined. Each article was screened to determine the following: total number of participants, the number of female participants and the number of male participants. The percentage of females and males per article in each of the journals was also calculated. Cross tabulations and Chi-square analysis were used to compare the gender representation of participants within each of the journals. Data were extracted from 1382 articles involving a total of 6,076,580 participants. A total of 2,366,968 (39%) participants were female and 3,709,612 (61%) were male. The average percentage of female participants per article across the journals ranged from 35% to 37%. Females were significantly under-represented across all of the journals (χ(2) = 23,566, df = 2, p < 0.00001). In conclusion, Sports and Exercise Medicine practitioners should be cognisant of sexual dimorphism and gender disparity in the current literature.
Article
Full-text available
The female hormones, oestrogen and progesterone, fluctuate predictably across the menstrual cycle in naturally cycling eumenorrhoeic women. Other than reproductive function, these hormones influence many other physiological systems, and their action during exercise may have implications for exercise performance. Although a number of studies have found exercise performance - and in particular, endurance performance - to vary between menstrual phases, there is an equal number of such studies reporting no differences. However, a comparison of the increase in the oestrogen concentration (E) relative to progesterone concentration (P) as the E/P ratio (pmol/nmol) in the luteal phase in these studies reveals that endurance performance may only be improved in the mid-luteal phase compared with the early follicular phase when the E/P ratio is high in the mid-luteal phase. Furthermore, the late follicular phase, characterized by the pre-ovulatory surge in oestrogen and suppressed progesterone concentrations, tends to promote improved performance in a cycling time trial and future studies should include this menstrual phase. Menstrual phase variations in endurance performance may largely be a consequence of changes to exercise metabolism stimulated by the fluctuations in ovarian hormone concentrations. The literature suggests that oestrogen may promote endurance performance by altering carbohydrate, fat and protein metabolism, with progesterone often appearing to act antagonistically. Details of the ovarian hormone influences on the metabolism of these macronutrients are no longer only limited to evidence from animal research and indirect calorimetry but have been verified by substrate kinetics determined with stable tracer methodology in eumenorrhoeic women. This review thoroughly examines the metabolic perturbations induced by the ovarian hormones and, by detailed comparison, proposes reasons for many of the inconsistent reports in menstrual phase comparative research. Often the magnitude of increase in the ovarian hormones between menstrual phases and the E/P ratio appear to be important factors determining an effect on metabolism. However, energy demand and nutritional status may be confounding variables, particularly in carbohydrate metabolism. The review specifically considers how changes in metabolic responses due to the ovarian hormones may influence exercise performance. For example, oestrogen promotes glucose availability and uptake into type I muscle fibres providing the fuel of choice during short duration exercise; an action that can be inhibited by progesterone. A high oestrogen concentration in the luteal phase augments muscle glycogen storage capacity compared with the low oestrogen environment of the early follicular phase. However, following a carbo-loading diet will super-compensate muscle glycogen stores in the early follicular phase to values attained in the luteal phase. Oestrogen concentrations of the luteal phase reduce reliance on muscle glycogen during exercise and although not as yet supported by human tracer studies, oestrogen increases free fatty acid availability and oxidative capacity in exercise, favouring endurance performance. Evidence of oestrogen's stimulation of 5'-AMP-activated protein kinase may explain many of the metabolic actions of oestrogen. However, both oestrogen and progesterone suppress gluconeogenic output during exercise and this may compromise performance in the latter stages of ultra-long events if energy replacement supplements are inadequate. Moreover, supplementing energy intake during exercise with protein may be more relevant when progesterone concentration is elevated compared with menstrual phases favouring a higher relative oestrogen concentration, as progesterone promotes protein catabolism while oestrogen suppresses protein catabolism. Furthermore, prospective research ideas for furthering the understanding of the impact of the menstrual cycle on metabolism and exercise performance are highlighted.
Article
Full-text available
Up to 5% of all hospital admissions are the result of adverse drug reactions (ADRs). Identifying those factors which may predispose to ADRs is essential for risk management. Amongst the known risk factors for adverse reactions are increasing age, polypharmacy, liver and renal disease as well as being female. Female patients have a 1.5- to 1.7-fold greater risk of developing an ADR, including adverse skin reactions, compared with male patients. The reasons for this increased risk are not entirely clear but include gender-related differences in pharmacokinetic, immunological and hormonal factors as well as differences in the use of medications by women compared with men. Women generally have a lower lean body mass, a reduced hepatic clearance, have differences in activity of cytochrome P450 (CYP) enzymes (40% increase in CYP3A4, varied decrease in CYP2D6, CYP2C19 and CYP1A2), and metabolize drugs at different rates compared with men. Other important factors include conjugation, absorption, protein binding and renal elimination, which may all have some gender-based differences. However, how these differences result in an increased risk of ADRs is not clear. There are pharmacodynamic differences between men and women, seen particularly with cardiac and psychotropic medications. There is no doubt that chlorpromazine, fluspirilene and various antipsychotics appear more effective in women than men for the same dosage and plasma concentration. Similarly, women are at increased risk of QT prolongation with certain anti-arrhythmic drugs compared with men even at equivalent serum concentrations. The mechanisms are unknown. Increasingly the evidence is that idiosyncratic drug reactions, particularly cutaneous reactions, appear to have an immunological etiology. It is possible that gender difference in T cell activation and proliferation account for this as well as the increased prevalence of skin diseases such as systemic lupus erythematosus and photosensitivity. Whatever the mechanism(s), it is important to be aware that gender is a significant factor in ADRs.
Article
Video slideshow introduction to the Symposium by Symposium Speaker A. William Sheel can be found here.